| Nome |
# |
|
Subcutaneous octreotide versus oral loperamide in the treatment of diarrhea following chemotherapy, file e3ad891a-5c06-da0e-e053-3705fe0a2b96
|
763
|
|
The role of histamine in doxorubicin and teniposide-induced cardiotoxicity in dog and mouse, file e3ad8923-09af-da0e-e053-3705fe0a2b96
|
660
|
|
4843delC of the BRCA1 gene is a possible founder mutation in Southern Italy (Sicily)., file e3ad8915-d150-da0e-e053-3705fe0a2b96
|
593
|
|
The TP53 colorectal cancer international collaborative study on the prognostic and predictive significance of p53 mutation: influence of tumor site, type of mutation, and adjuvant treatment, file e3ad8915-d530-da0e-e053-3705fe0a2b96
|
543
|
|
Influenza del suolo sulla produzione di Ocratossina A lungo la filiera vitivinicola, file e3ad8916-958e-da0e-e053-3705fe0a2b96
|
494
|
|
Prognostic vs predictive molecular biomarkers in colorectal cancer: is KRAS and BRAF wild type status required for anti-EGFR therapy?, file e3ad891a-3209-da0e-e053-3705fe0a2b96
|
400
|
|
EGFR genomic alterations in cancer: prognostic and predictive values, file e3ad8917-5492-da0e-e053-3705fe0a2b96
|
383
|
|
Havep53 gene mutations and protein expression a different biological significance in colorectal cancer?, file e3ad8916-8501-da0e-e053-3705fe0a2b96
|
368
|
|
Prognostic and predictive factors in colorectal cancer: Kirsten Ras in CRC
(RASCAL) and TP53CRC collaborative studies., file e3ad8915-d532-da0e-e053-3705fe0a2b96
|
331
|
|
TP53 mutations and S-phase fraction but not DNA-ploidy are independent prognostic indicators in laryngeal squamous cell carcinoma, file e3ad8915-f19c-da0e-e053-3705fe0a2b96
|
324
|
|
BRCA1 genetic testing in 106 breast and ovarian cancer families from southern Italy (Sicily): a mutation analyses., file e3ad8915-e52e-da0e-e053-3705fe0a2b96
|
288
|
|
Anti-endothelin drugs in solid tumors, file e3ad8917-57be-da0e-e053-3705fe0a2b96
|
280
|
|
Primary extranodal non-Hodgkin lymphomas of the uterus and the breast: report of three cases, file e3ad891a-9311-da0e-e053-3705fe0a2b96
|
263
|
|
Design, synthesis, and biological evaluation of novel aminobisphosphonates possessing an in vivo antitumor activity through a gammadelta-T lymphocytes-mediated activation mechanism., file e3ad8915-e99a-da0e-e053-3705fe0a2b96
|
254
|
|
Gastrointestinal stromal tumors (GISTs): focus on histopathological diagnosis and
biomolecular features, file e3ad8915-d0cc-da0e-e053-3705fe0a2b96
|
224
|
|
Bisphosphonate-related osteonecrosis of the jaw (BRONJ): run dental management
designs and issues in diagnosis., file e3ad8915-d157-da0e-e053-3705fe0a2b96
|
216
|
|
Specific TP53 and/or Ki-ras mutations as independent predictors of clinical
outcome in sporadic colorectal adenocarcinomas: results of a 5-year Gruppo
Oncologico dell'Italia Meridionale (GOIM) prospective study., file e3ad891a-5380-da0e-e053-3705fe0a2b96
|
198
|
|
Clinical presentation and treatment of gastrointestinal stromal tumors., file e3ad891a-382f-da0e-e053-3705fe0a2b96
|
197
|
|
BRAFV600E Mutation and p27kip1 Expression in
Papillary Carcinomas of the Thyroid ≤1 cm and
Their Paired Lymph Node Metastases, file e3ad8915-c45d-da0e-e053-3705fe0a2b96
|
175
|
|
Differential expression levels of urokinase-type plasminogen activator and cathepsin D in locally advanced laryngeal squamous cell carcinoma: Clinical implications, file e3ad8923-1b38-da0e-e053-3705fe0a2b96
|
168
|
|
Angiogenesis modifications related with cetuximab plus irinotecan as anticancer treatment in advanced colorectal cancer patients., file e3ad8915-dc77-da0e-e053-3705fe0a2b96
|
161
|
|
Gemcitabine-based doublets versus single-agent therapy for elderly patients with advanced nonsmall cell lung cancer: a Literature-based Meta-analysis., file e3ad8915-d0c1-da0e-e053-3705fe0a2b96
|
139
|
|
Effects of E-64 (cysteine-proteinase inhibitor) and Pepstatin (aspartyl-proteinase inhibitor) on metastasis formation in mice with mammary and ovarian tumors, file e3ad8923-1102-da0e-e053-3705fe0a2b96
|
126
|
|
Pemetrexed single agent chemotherapy in previously treated patients with locally advanced or metastatic non-small cell lung cancer., file e3ad8915-e998-da0e-e053-3705fe0a2b96
|
122
|
|
“Modulation of 5-fluorouracil as adjuvant systemic chemotherapy in colorectal cancer:the IGCS-COL multicentre, randomised, phase III study”, file e3ad8915-be18-da0e-e053-3705fe0a2b96
|
81
|
|
Emotional expression and coping style in female breast cancer., file e3ad8915-d151-da0e-e053-3705fe0a2b96
|
74
|
|
MMP-2, MMP-9 and activin A blood levels in patients with breast cancer or prostate cancer metastatic to the bone., file e3ad891d-96f4-da0e-e053-3705fe0a2b96
|
64
|
|
Activin A circulating levels in patients with bone metastasis from breast or prostate cancer, file e3ad8917-15e1-da0e-e053-3705fe0a2b96
|
63
|
|
Gemcitabine and oxaliplatin combination chemotherapy in advanced biliary tract cancers, file e3ad891a-4e07-da0e-e053-3705fe0a2b96
|
46
|
|
The use of zoledronic acid in patients with bone metastases from prostate carcinoma: effect on analgesic response and bone metabolism biomarkers, file e3ad8917-1414-da0e-e053-3705fe0a2b96
|
38
|
|
Functional categories of TP53 mutation in colorectal cancer: results of an International Collaborative Study., file e3ad8915-e558-da0e-e053-3705fe0a2b96
|
36
|
|
Triplet schedule of weekly 5-Fluorouracil and alternating irinotecan or oxaliplatin in advanced colorectal cancer: A dose-finding and phase II study, file e3ad8916-7d12-da0e-e053-3705fe0a2b96
|
34
|
|
Cathepsin D expression levels in nongynecological solid tumors: Clinical and therapeutic implications, file e3ad8917-11b5-da0e-e053-3705fe0a2b96
|
34
|
|
DNA aneuploidy and high proliferative activity but not K-ras-2 mutations as independent predictors of clinical outcome in operable gastric carcinoma: Results of a 5-year Gruppo Oncologico dell'Italia Meridionale (GOIM) prospective study, file e3ad8923-45d8-da0e-e053-3705fe0a2b96
|
28
|
|
Effects of zoledronic acid on proteinase plasma levels in patients with bone metastases., file e3ad8915-eeb6-da0e-e053-3705fe0a2b96
|
27
|
|
TP53 in gastric cancer: mutations in the l3 loop and LSH motif DNA-binding domains of TP53 predict poor outcome, file e3ad891a-56a7-da0e-e053-3705fe0a2b96
|
27
|
|
Aurora-A overexpression as an early marker of reflux-related columnar mucosa and Barrett's oesophagus., file e3ad8915-d155-da0e-e053-3705fe0a2b96
|
26
|
|
Ductal lavage: a way of carefully tracing the breast-secreting duct, file e3ad8915-dc76-da0e-e053-3705fe0a2b96
|
26
|
|
Bortezomib: a new pro-apoptotic agent in cancer treatment., file e3ad891f-403d-da0e-e053-3705fe0a2b96
|
21
|
|
Overexpression of cyclin D1 and interaction between p27(Kip1) and tumour thickness predict lymph node metastases occurrence in lower lip squamous cell carcinoma, file e3ad8919-4680-da0e-e053-3705fe0a2b96
|
18
|
|
null, file e3ad8917-11b6-da0e-e053-3705fe0a2b96
|
16
|
|
p53 mutations in L3-loop zinc-binding domain, DNA-ploidy, and S phase fraction are independent prognostic indicators in colorectal cancer: A prospective study with a five-year follow-up, file e3ad8916-75e3-da0e-e053-3705fe0a2b96
|
15
|
|
Hereditary common cancers: Molecular and clinical genetics, file e3ad8922-f249-da0e-e053-3705fe0a2b96
|
15
|
|
Targeting human {gamma}delta} T cells with zoledronate and interleukin-2 for immunotherapy of hormone-refractory prostate cancer., file e3ad8915-eeb5-da0e-e053-3705fe0a2b96
|
11
|
|
Tumor markers in urogynaecological tumors., file e3ad891e-d645-da0e-e053-3705fe0a2b96
|
8
|
|
miR-20b Modulates VEGF
Expression by Targeting HIF-1a
and STAT3 in MCF-7 Breast
Cancer Cells, file e3ad8915-eafa-da0e-e053-3705fe0a2b96
|
3
|
|
The use of pegylated liposomal doxorubicin (PLD) in association with weekly paclitaxel as second line therapy in metastatic bladder carcinoma: final results, file e3ad8915-ed63-da0e-e053-3705fe0a2b96
|
3
|
|
Cathepsin D: A possible biochemical marker for anthracycline cardiomyopathy, file e3ad8923-09b0-da0e-e053-3705fe0a2b96
|
3
|
|
Antimetastatic activity of adriamycin in combinations with proteinase inhibitors in mice, file e3ad8923-0de2-da0e-e053-3705fe0a2b96
|
3
|
|
Lysosomal alterations in heart and liver of mice treated with doxorubicin, file e3ad8923-32e2-da0e-e053-3705fe0a2b96
|
3
|
|
Bortezomib: a new pro-apoptotic agent in cancer treatment., file e3ad8915-eb02-da0e-e053-3705fe0a2b96
|
2
|
|
Alexithymia and coping style in women going to visit in a breast cancer center., file e3ad891d-5706-da0e-e053-3705fe0a2b96
|
2
|
|
Cathepsin D content in colorectal cancer, file e3ad8922-f065-da0e-e053-3705fe0a2b96
|
2
|
|
DNA ploidy and S-phase fraction, but not p53 or NM23-H1 expression, predict outcome in colorectal cancer patients. Result of a 5-year prospective study, file e3ad8922-f240-da0e-e053-3705fe0a2b96
|
2
|
|
Pepstatins: Aspartic proteinase inhibitors having potential therapeutic applications, file e3ad8923-0650-da0e-e053-3705fe0a2b96
|
2
|
|
Prognostic significance of p16INK4a alterations and 9p21 loss of heterozigosity in locally advanced laryngeal squamous cell carcinoma, file e3ad8923-287d-da0e-e053-3705fe0a2b96
|
2
|
|
Kinetics of in vivo inhibition of tissue cathepsin d by pepstatin A, file e3ad8923-4b77-da0e-e053-3705fe0a2b96
|
2
|
|
Cathepsin D, B and L circulating levels as prognostic markers of malignant progression, file e3ad8923-4c5b-da0e-e053-3705fe0a2b96
|
2
|
|
Acute myocardial effects of mitoxantrone in the rabbit, file e3ad8923-4c65-da0e-e053-3705fe0a2b96
|
2
|
|
Haemopoietic effects of 7 alpha, 17 beta Dimethyltestosterone, file e3ad8923-4c66-da0e-e053-3705fe0a2b96
|
2
|
|
Galangin increases the cytotoxic activity of imatinib mesylate in imatinib-sensitive and imatinib-resistant Bcr-Abl expressing leukemia cells, file e3ad8915-e381-da0e-e053-3705fe0a2b96
|
1
|
|
PML expression in soft tissue sarcoma: prognostic value in alkilating agents/anthracyclin based first line therapy, file e3ad8915-e7f3-da0e-e053-3705fe0a2b96
|
1
|
|
Driver mutations and differential sensitivity to targeted therapies: a new approach to the treatment of lung adenocarcinoma, file e3ad8915-f1dd-da0e-e053-3705fe0a2b96
|
1
|
|
PML down-regulation in soft tissue sarcomas., file e3ad891d-41fe-da0e-e053-3705fe0a2b96
|
1
|
|
Irinotecan (CPT-11) and mitomycin-C (MMC) as second-line therapy in advanced gastric cancer: a phase II study of the Gruppo Oncologico dell' Italia Meridionale (prot. 2106)., file e3ad891d-d3cf-da0e-e053-3705fe0a2b96
|
1
|
|
Gemcitabine (GEM) plus oxaliplatin, folinic acid, and 5-fluorouracil (FOLFOX-4) in patients with advanced gastric cancer., file e3ad891d-f0c0-da0e-e053-3705fe0a2b96
|
1
|
|
Studies on the apoptotic activity of natural and synthetic retinoids: discovery of a new class of synthetic terphenyls that potently support cell growth and inhibit apoptosis in neuronal and HL-60 cells, file e3ad891d-fd62-da0e-e053-3705fe0a2b96
|
1
|
|
A phase i-II study of cyclophosphamide, epidoxorubicin, levofolinic acid/5-fluorouracil and recombinant human granulocyte colony stimulating factor in metastatic breast carcinoma, file e3ad8922-8f11-da0e-e053-3705fe0a2b96
|
1
|
|
Flow cytometric DNA analysis and lysosomal cathepsins b and l in locally advanced laryngeal cancer. Relationship with clinicopathologic parameters and prognostic significance, file e3ad8922-f062-da0e-e053-3705fe0a2b96
|
1
|
|
Lysosomal aspartic and cysteine proteinases serum levels in patients with pancreatic cancer or pancreatitis, file e3ad8922-f068-da0e-e053-3705fe0a2b96
|
1
|
|
Effects of amsacrine (m-AMSA) a new aminoacridine antitumor drug, on the rabbit heart, file e3ad8922-fdfe-da0e-e053-3705fe0a2b96
|
1
|
|
Stefin A and cathepsin B and L circulating serum levels in patients with malignant or non-malignant liver diseases: A preliminary report, file e3ad8923-0648-da0e-e053-3705fe0a2b96
|
1
|
|
Cathepsin D Serum Mass Concentrations in Patients with Hepatocellular Carcinoma and/or Liver Cirrhosis, file e3ad8923-1837-da0e-e053-3705fe0a2b96
|
1
|
|
Cathepsin D activity levels in colorectal cancer: Correlation with cathepsin B and L and other biological and clinical parameters, file e3ad8923-267b-da0e-e053-3705fe0a2b96
|
1
|
|
Ras family genes: An interesting link between cell cycle and cancer, file e3ad8923-2873-da0e-e053-3705fe0a2b96
|
1
|
|
Specific codon 13 K-ras mutations are predictive of clinical outcome in colorectal cancer patients, whereas codon 12 K-ras mutations are associated with mucinous histotype, file e3ad8923-2877-da0e-e053-3705fe0a2b96
|
1
|
|
Cathepsin D in the malignant progression of neoplastic diseases, file e3ad8923-32ec-da0e-e053-3705fe0a2b96
|
1
|
|
Lysosomal Cathepsins B and L and Stef in A Blood Levels in Patients with Hepatocellular Carcinoma and/or Liver Cirrhosis: Potential Clinical Implications, file e3ad8923-4520-da0e-e053-3705fe0a2b96
|
1
|
|
STAT Proteins: From Normal Control of Cellular Events to Tumorigenesis, file e3ad8923-45d6-da0e-e053-3705fe0a2b96
|
1
|
| Totale |
8.432 |